Post $2 bn investment in Manipal Hospital, Singapore fund scouting for more investments
Dev Chatterjee Mumbai
Vishesh Shrivastav, MD Temasek India
2 min read
Last Updated :
Apr 25 2023 | 7:58 AM
IST
Listen to This Article
Your browser does not support the audio element.
Temasek, the Singapore-based fund, is looking to invest in the Indian consumer retail, healthcare and technology companies after it made its blockbuster $2 billion investment in Manipal Health Enterprises to increase its stake to 59 per cent.
“Since 2004, we have been investing on an average $1 billion per annum in India across technology, telecom and consumer retail sectors. We are long term investors and are scouting for opportunities in several sectors,” Vishesh Shrivastav, Managing Director, Investment (India), of Temasek said.
While each investment made in India has to compete for capital with projects across the world in the fund, Shrivastav said India offers favourable demographics, aspirational population, and high class of entrepreneurs. “Stable policies and creation of good infrastructure is another big positive for India,” he said. “We are sector agnostic and investing in four broad themes such as the future of consumption, digitisation, sustainable living and longer lifespans,” he said.
The fund is an investor in Tata Play, the satellite TV broadcaster, Zomato,a food delivery app, Ola Electric and Intas pharma. The fund has also invested in Ascendas – which is building greenfield warehouses across India.
On April 18th, Temasek signed definitive agreements to acquire an additional 41 per cent stake in Manipal Hospital apart from holding 18 per cent via Sheares Healthcare Group, a wholly-owned subsidiary of Temasek. The promoters of Manipal will hold about 30 percent of MHE. Global fund TPG will hold an interest of 11 per cent in MHE, through its new Asia fund – TPG Asia VIII while National Investment & Infrastructure Fund (NIIF) will exit its holding from MHE.
Shrivastav said the healthcare investment is part of its strategy to invest in healthcare, pharmaceutical and diagnostic segments. “We would like to do more deals in this space as we see better returns going forward,” he said.
Also Read
Manipal Health aims adding 3,600 beds yrs after Temasek controlling stake
January retail inflation rises to 6.52%, highest since October 2022
HealthKart raises $135 million in funding from Temasek, A91 Partners
Temasek buys majority stake in Manipal Health in largest wellness deal
Retail inflation eases marginally to 6.44% in February from 6.52% in Jan
Govt set to approve Micron Technology’s $1-billion semiconductor plant
Eye on CSR Part-II: FY22 spend near target, thanks to white knights
Ipca Laboratories to acquire 33% stake in Unichem for 1,034 crore
Changes in contract within boundaries of law: Air India management
JSW Group in talks with MG Motor India, BYD India to pick up stake
“We are extremely satisfied with the returns from India and have made steady exits over the years.”
The fund is also bullish on the renewable energy sector where its investee company O2 Power is constructing 3 gigawatts of renewable power projec
Temasek India investments
Future of Consumption: Godrej Consumer Products, Crompton Greaves Consumer Electricals, Devyani International
Digitisation: Zomato, Tata Play, HealthKart
Sustainable Living: DeHaat, Ola Electric, O2 Power
Longer Lifespans: Manipal Health Enterprises, Intas Pharmaceuticals, Integrace
First Published: Apr 24 2023 | 11:48 PM IST
